Skip to content

Clinical trials

Diabetes Mellitus, Type 2 trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Country / region: Russia Clear all

304 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20022
20037
20044
20059
200618
200717
200832
200932
201027
201116
201221
201314
201412
201510
201614
201719
201812
20198
20208
20217
20224
20232
20242
20255
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed274
Terminated21
Unknown status4
Active, not recruiting2
Recruiting2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S59
AstraZeneca37
Sanofi31
Boehringer Ingelheim25
Eli Lilly and Company25
Hoffmann-La Roche15
GlaxoSmithKline11
Takeda11
Janssen Research & Development, LLC10
Mannkind Corporation8

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 2304
Diabetes Mellitus99
Hyperglycemia11
Diabetes Mellitus, Type 110
Glucose Metabolism Disorders9
Metabolic Diseases8
Renal Insufficiency, Chronic8
Insulin Resistance7
Endocrine System Diseases6
Heart Failure6

Trials

Showing 51 to 75 of 304. Each trial links to its page on Pharma Observatory.

204 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.